Table 1.
Main patients characteristics
| Characteristics | Parameters | Values |
|---|---|---|
| Age |
Mean |
54.9 |
| Median |
55 |
|
| Range |
30-74 |
|
| Karnofsky Performance Status |
Median |
90 |
| Range |
80–100 |
|
| Body Mass Index |
Mean |
24.3 |
| Median |
24 |
|
| Range |
20-32 |
|
| Breast Side |
Right |
24 (58.5%) |
| Left |
17 (41.5%) |
|
| Pathological Tumor Stage |
Tis |
2 (4.9%) |
| T1 |
29 (70.7%) |
|
| T2 |
10 (24.4%) |
|
| Pathological Nodal Stage |
N0 |
28 (68.3%) |
| N1 |
13 (31.7%) |
|
| Surgery |
Conservative surgery + biopsy of sentinel node |
28 (68.3%) |
| Conservative surgery + axillary node dissection |
13 (31.7%) |
|
| Histology |
Ductal infiltring carcinoma |
31 (75.6%) |
| Lobular infiltring carcinoma |
5 (12.2%) |
|
| Mixed carcinoma |
3 (7.3%) |
|
| In-situ ductal carcinoma |
2 (4.9%) |
|
| Estrogen/Progesteron Receptors |
Positive |
27 (65.9%) |
| Negative |
14 (34.1%) |
|
| Anti-Hormone Therapy |
Yes |
19 (46.3%) |
| No |
22 (53.7%) |
|
| Adjuvant Chemotherapy |
Yes |
10 (24.4%) |
| No |
31 (75.6%) |
|
| Optimal Position | Prone |
29 (70.7%) |
| Supine | 12 (29.3%) |